OUR WORK

How It’s Done

We believe that collaboration breeds purpose-built creative, founded on insights and made to cut through the clutter of today's landscape. See for yourself.

We keep good company

Our independent spirit is on display in the range of clients and projects that we've collaborated with and on. Providing solutions to communications challenges, whether for a start-up biotech or an established pharmaceutical company, is what we do.

Recent work

Explore recent case studies below to see how we bring each client's vision to life.

SKYTROFA^®

DISRUPTING THE MARKET

SKYTROFA^® for pediatric growth hormone deficiency

For decades, the growth hormone market was dominated by daily injections—a burdensome routine for children, their families, and their doctors.
Motivated to help address these needs, Wedgewood not only promoted the convenience and flexibility of once-weekly SKYTROFA at launch but drove awareness of its unique technology, delivering the same trusted molecule as daily injections. In the years following, we used SKYTROFA's long-term clinical results to position it against other long-acting growth hormone options that came to market.

OFEV^®

THREE INDICATIONS, ONE GOAL

OFEV^® for idiopathic pulmonary fibrosis, chronic interstitial lung disease, and systemic sclerosis-associated interstitial lung disease

For patients facing progressive lung diseases, it can be hard to comprehend what to expect when living with their condition and how they and their loved ones will need to adapt their lives.
Understanding the need for a clear and compassionate approach, Wedgewood developed a campaign customized for each indication that effectively communicated the impact of the disease to patients and empowered them in preparing for the road ahead.

LUPKYNIS^®

IDENTIFYING THE PATIENT

LUPKYNIS^® for lupus nephritis

Despite high awareness, healthcare professionals were unsure of the appropriate patient type for LUPKYNIS. Wedgewood developed a campaign that portrayed a strong sense of the LUPKYNIS patient, featuring real patient imagery to give a face to this rare disease.
In developing this campaign, Wedgewood’s goal was to take healthcare professionals’ existing awareness of LUPKYNIS and empower them to do more for their patients with lupus nephritis. This campaign works to elevate the risk of uncontrolled lupus nephritis and the impact of achieving a greater complete response to improve patient outcomes.

AZSTARYS^®

TIME TO SHINE

AZSTARYS^® for attention deficit hyperactivity disorder in children and adults

In a market saturated with ADHD treatment options, how do you stand out? Wedgewood was tasked with redefining what ADHD represents while resonating with the experiences of patients and healthcare professionals. Using insights and inspiration from the brand name itself, Wedgewood created the “a star is” campaign, which highlights each patient’s ability to meet the demands and challenges of their day with AZSTARYS and the healthcare professional’s role in supporting their needs.